Founded 2007 in Winterthur, Switzerland. SIS Medical has always been and will still be dedicated to develop, produce and distribute innovative high performance PTCA Balloon Catheters, which are designed to facilitate the daily work of the user, help to extent treatment options and to improve the quality of live of patients .
Our target is to provide best in class devices for an optimal lesion preparation prior to stent (DES) implantation (including Scaffolds, BVS) in order to optimize long term clinical outcomes.
We are convinced that our range of high and super high pressure PTCA balloons, like the BEO NC, low profile, high pressure balloon and the OPN NC super high pressure PTCA balloon (RBP 35 atm), incorporating an unique twin wall balloon construction, are the answer to successfully target unmet clinical needs, as for example, undilatable lesions, in-stent restenosis (ISR) aso…
In October 2015, the SHS Investment Group, Tübingen Germany; ( www.shs-capital.eu ) has become the major shareholder of SIS Medical AG
SHS, founded in 1993 is an independent private equity company, located in Tübingen, Germany with the focus on investments in the MedTech and Life Sciences sector. SHS, with it`s vast experience in this field is investing and supporting the development and growth of SIS Medical with the goal to transform a promising young company into a worldwide successfully operating entity.
As a first result of the new major shareholdership, SIS MEDICAL AG has moved in May 2016 to new facilities in Frauenfeld, Switzerland, establishing the base, for further successful growth with the target to become a leading company in the field of vascular interventions and to be represented worldwide.
SIS MEDICAL – Swiss Interventional Systems „ On the move to new frontiers „ has already become part of reality.
The success story is continuing. You are kindly invited to follow us and become a part of it.